| 1 |
Khera R, Schuemie MJ, Lu Y, Ostropolets A, Chen R, Hripcsak G, Ryan PB, Krumholz HM, Suchard MA. Large-scale evidence generation and evaluation across a network of databases for type 2 diabetes mellitus (LEGEND-T2DM): a protocol for a series of multinational, real-world comparative cardiovascular effectiveness and safety studies. BMJ Open 2022;12:e057977. [PMID: 35680274 DOI: 10.1136/bmjopen-2021-057977] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 2 |
Ito M, Higashigawa M. Effectiveness of self-financed rotavirus vaccination in Ise City, Japan. Hum Vaccin Immunother 2021;:1-6. [PMID: 34641737 DOI: 10.1080/21645515.2021.1972706] [Reference Citation Analysis]
|
| 3 |
Khera R, Scheumie MJ, Lu Y, Ostropolets A, Chen R, Hripcsak G, Ryan PB, Krumholz HM, Suchard MA. RESEARCH PROTOCOL: Large-scale evidence generation and evaluation across a network of databases for type 2 diabetes mellitus.. [DOI: 10.1101/2021.09.27.21264139] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 4 |
Inns T, Fleming KM, Iturriza-Gomara M, Hungerford D. Paediatric rotavirus vaccination, coeliac disease and type 1 diabetes in children: a population-based cohort study. BMC Med 2021;19:147. [PMID: 34183004 DOI: 10.1186/s12916-021-02017-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 5 |
Butler AM, Breskin A, Sahrmann JM, Brookhart MA. Estimating the Effectiveness of Rotavirus Vaccine Schedules. Epidemiology 2021;32:598-606. [PMID: 33927157 DOI: 10.1097/EDE.0000000000001363] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 6 |
Gessner BD, Isturiz R, Snow V, Grant LR, Theilacker C, Jodar L. The rationale for use of clinically defined outcomes in assessing the impact of pneumococcal conjugate vaccines against pneumonia. Expert Rev Vaccines 2021;20:269-80. [PMID: 33602035 DOI: 10.1080/14760584.2021.1889376] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 7 |
van Dongen JAP, Rouers EDM, Schuurman R, Bonten MJM, Bruijning-Verhagen P; RIVAR Study Group. Acute Gastroenteritis Disease Burden in Infants With Medical Risk Conditions in the Netherlands. Pediatr Infect Dis J 2021;40:300-5. [PMID: 33230056 DOI: 10.1097/INF.0000000000003002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 8 |
Muchaal PK, Hurst M, Desai S. The impact of publicly funded rotavirus immunization programs on Canadian children. Can Commun Dis Rep 2021;47:97-104. [PMID: 33746618 DOI: 10.14745/ccdr.v47i02a02] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 9 |
Escolano S, Mueller JE, Tubert-bitter P. Accounting for indirect protection in the benefit–risk ratio estimation of rotavirus vaccination in children under the age of 5 years, France, 2018. Eurosurveillance 2020;25. [DOI: 10.2807/1560-7917.es.2020.25.33.1900538] [Reference Citation Analysis]
|
| 10 |
Pitzer VE, Bennett A, Bar-Zeev N, Jere KC, Lopman BA, Lewnard JA, Parashar UD, Cunliffe NA. Evaluating strategies to improve rotavirus vaccine impact during the second year of life in Malawi. Sci Transl Med 2019;11:eaav6419. [PMID: 31413144 DOI: 10.1126/scitranslmed.aav6419] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 11 |
Solastie A, Leino T, Ollgren J. Success of rotavirus vaccination in Finland, a register based study measuring impact beyond overall effectiveness. Vaccine 2020;38:3766-72. [DOI: 10.1016/j.vaccine.2020.03.022] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 12 |
Olson DR, Lopman BA, Konty KJ, Mathes RW, Papadouka V, Ternier A, Zucker JR, Simonsen L, Grenfell BT, Pitzer VE. Surveillance data confirm multiyear predictions of rotavirus dynamics in New York City. Sci Adv 2020;6:eaax0586. [PMID: 32133392 DOI: 10.1126/sciadv.aax0586] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 13 |
Baker JM, Dahl RM, Cubilo J, Parashar UD, Lopman BA. Effects of the rotavirus vaccine program across age groups in the United States: analysis of national claims data, 2001-2016. BMC Infect Dis 2019;19:186. [PMID: 30795739 DOI: 10.1186/s12879-019-3816-7] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 14 |
van Wijhe M, McDonald SA, de Melker HE, Postma MJ, Wallinga J. Estimating the Population-Level Effectiveness of Vaccination Programs in the Netherlands. Epidemiology 2018;29:215-23. [PMID: 29087989 DOI: 10.1097/EDE.0000000000000778] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 15 |
Pietsch C, Liebert U. Rotavirus vaccine effectiveness in preventing hospitalizations due to gastroenteritis: a descriptive epidemiological study from Germany. Clinical Microbiology and Infection 2019;25:102-6. [DOI: 10.1016/j.cmi.2018.03.046] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 16 |
Lopez Bernal JA, Andrews N, Amirthalingam G. The Use of Quasi-experimental Designs for Vaccine Evaluation. Clinical Infectious Diseases 2019;68:1769-76. [DOI: 10.1093/cid/ciy906] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 17 |
Hungerford D, Vivancos R, Read JM, Bonnett LJ, Bar-Zeev N, Iturriza-Gómara M, Cunliffe NA, French N. Mitigating bias in observational vaccine effectiveness studies using simulated comparator populations: Application to rotavirus vaccination in the UK. Vaccine 2018;36:6674-82. [PMID: 30293764 DOI: 10.1016/j.vaccine.2018.09.051] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 18 |
Getachew HB, Dahl RM, Lopman BA, Parashar UD. Rotavirus Vaccines and Health Care Utilization for Diarrhea in US Children, 2001 to 2015. Pediatr Infect Dis J 2018;37:943-8. [PMID: 29561514 DOI: 10.1097/INF.0000000000001988] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 19 |
Layton JB, Butler AM, Panozzo CA, Brookhart MA. Rotavirus vaccination and short-term risk of adverse events in US infants. Paediatr Perinat Epidemiol 2018;32:448-57. [PMID: 30048564 DOI: 10.1111/ppe.12496] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 20 |
Franceschi S, Clifford GM, Baussano I. Options for design of real-world impact studies of single-dose vaccine schedules. Vaccine 2018;36:4816-22. [PMID: 29571973 DOI: 10.1016/j.vaccine.2018.02.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 21 |
Rosettie KL, Vos T, Mokdad AH, Flaxman AD, Khalil I, Troeger C, Weaver MR. Indirect Rotavirus Vaccine Effectiveness for the Prevention of Rotavirus Hospitalization: A Systematic Review and Meta-Analysis. Am J Trop Med Hyg 2018;98:1197-201. [PMID: 29436336 DOI: 10.4269/ajtmh.17-0705] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 22 |
Parashar UD, Cortese MM, Offit PA. Rotavirus Vaccines. Plotkin's Vaccines 2018. [DOI: 10.1016/b978-0-323-35761-6.00051-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 23 |
Hungerford D, Smith K, Tucker A, Iturriza-Gómara M, Vivancos R, McLeonard C, A Cunliffe N, French N. Population effectiveness of the pentavalent and monovalent rotavirus vaccines: a systematic review and meta-analysis of observational studies. BMC Infect Dis 2017;17:569. [PMID: 28810833 DOI: 10.1186/s12879-017-2613-4] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 24 |
Halloran ME, Hudgens MG. Estimating population effects of vaccination using large, routinely collected data. Stat Med 2018;37:294-301. [PMID: 28722190 DOI: 10.1002/sim.7392] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 25 |
Immergluck LC, Parker TC, Jain S, Laghaie E, Spandorfer P, Jerris RC, Bowen MD, Parashar UD, Cortese MM. Sustained Effectiveness of Monovalent and Pentavalent Rotavirus Vaccines in Children. J Pediatr 2016;172:116-120.e1. [PMID: 26935786 DOI: 10.1016/j.jpeds.2016.01.042] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 26 |
Wu JT, Jit M, Zheng Y, Leung K, Xing W, Yang J, Liao Q, Cowling BJ, Yang B, Lau EH, Takahashi S, Farrar JJ, Grenfell BT, Leung GM, Yu H. Routine Pediatric Enterovirus 71 Vaccination in China: a Cost-Effectiveness Analysis. PLoS Med 2016;13:e1001975. [PMID: 26978565 DOI: 10.1371/journal.pmed.1001975] [Cited by in Crossref: 28] [Cited by in F6Publishing: 32] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 27 |
Doll MK, Buckeridge DL, Morrison KT, Gagneur A, Tapiero B, Charest H, Quach C. Effectiveness of monovalent rotavirus vaccine in a high-income, predominant-use setting. Vaccine 2015;33:7307-14. [DOI: 10.1016/j.vaccine.2015.10.118] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 28 |
Mohammed A, Immergluck L, Parker TC, Jain S, Leong T, Anderson EJ, Jerris RC. Association between mixed rotavirus vaccination types of infants and rotavirus acute gastroenteritis. Vaccine 2015;33:5670-7. [PMID: 26322843 DOI: 10.1016/j.vaccine.2015.08.027] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 29 |
Pollard SL, Malpica-llanos T, Friberg IK, Fischer-walker C, Ashraf S, Walker N. Estimating the herd immunity effect of rotavirus vaccine. Vaccine 2015;33:3795-800. [DOI: 10.1016/j.vaccine.2015.06.064] [Cited by in Crossref: 53] [Cited by in F6Publishing: 55] [Article Influence: 6.6] [Reference Citation Analysis]
|
| 30 |
Redondo O, Cano R, Simón L. Decline in rotavirus hospitalizations following the first three years of vaccination in Castile-La Mancha, Spain. Hum Vaccin Immunother 2015;11:769-75. [PMID: 25644531 DOI: 10.1080/21645515.2015.1009339] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 31 |
Halloran ME, Longini IM Jr. Emerging, evolving, and established infectious diseases and interventions. Science 2014;345:1292-4. [PMID: 25214617 DOI: 10.1126/science.1254166] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 32 |
Roué JM, Nowak E, Le Gal G, Lemaitre T, Oger E, Poulhazan E, Giroux JD, Garenne A, Gagneur A. Impact of rotavirus vaccine on premature infants. Clin Vaccine Immunol 2014;21:1404-9. [PMID: 25080553 DOI: 10.1128/CVI.00265-14] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
|
